Fig. 3From: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Konga ROC curve analysis shows that the optimal cut-off level of AFP at the start of DAA therapy for predicting HCC development was 10.5 ng/mL (sensitivity 80%, specificity 84.2%, Area under the ROC curve = 0.868). b Cumulative incidence of HCC, stratified by the AFP level at the start of DAA therapyBack to article page